CNXU Conexeu Sciences Inc.
Fundamentals / CIK 0002066836 / USDConexeu Sciences Inc. reported $7.16M in total assets through July 31, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNXU in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Jul 31, 2026
-
Operating Income FY 2026-- Operating profit
-
Net Income FY 2026-- GAAP bottom line
-
Diluted EPS FY 2026-- Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Jul 31, 2026$1.97M Total debt: $72K
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-07-31 | 2026-04-30 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Research & Development | $270K | $67K | $135K | $42K |
| Total Operating Expenses | $7.69M | $2.38M | $1.30M | $457K |
| Operating Income | -$7.69M | -$2.38M | -$1.30M | -$457K |
| EBITDA | -$7.68M | -$2.37M | -$1.29M | -$454K |
| Interest Income | $34K | $84K | $386 | $0 |
| Interest Expense | $0 | $0 | -$43 | $1.4K |
| Income Before Tax | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Income Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Basic EPS | -$0.29 | -$0.11 | -$0.09 | -$0.05 |
| Diluted EPS | -$0.29 | -$0.11 | -$0.09 | -$0.05 |
| Basic Shares Outstanding | 27.0M | 20.6M | 14.1M | 9.5M |
| Diluted Shares Outstanding | 27.0M | 20.6M | 14.1M | 9.5M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-07-31 | 2026-04-30 | 2025-10-31 |
|---|---|---|---|
| Cash & Cash Equivalents | $1.97M | $6.85M | $4.81M |
| Cash & Short-Term Investments | $1.97M | $6.85M | $4.81M |
| Total Current Assets | $6.76M | $7.91M | $7.46M |
| Property, Plant & Equipment, Net | $74K | $38K | $11K |
| Intangible Assets | $164K | $164K | $177K |
| Total Non-Current Assets | $400K | $286K | $230K |
| Total Assets | $7.16M | $8.20M | $7.69M |
| Total Current Liabilities | $1.27M | -- | $336K |
| Total Non-Current Liabilities | $33K | -- | $0 |
| Total Liabilities | $1.31M | $1.00M | $336K |
| Total Debt (incl. Leases) | $72K | -- | -- |
| Common Stock | $27K | $21K | $19K |
| Retained Earnings | -$16.27M | -$8.54M | -$4.52M |
| Total Stockholders' Equity | $5.85M | $7.20M | $7.35M |
| Total Equity | $5.85M | $7.20M | $7.35M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-07-31 | 2026-04-30 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Net Income | -$7.73M | -$2.30M | -$1.30M | -$458K |
| Depreciation & Amortization | $5.4K | $11K | $6.6K | $3.4K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-07-31 | 2026-04-30 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Current Ratio | 5.31x | -- | -- | -- |
| Quick Ratio | 1.55x | -- | -- | -- |
| Debt to Equity | 0.01x | -- | -- | -- |